CERO

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO)

About CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO)

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in South San Francisco, CA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.66
52 Week Low
$0.01
Market cap
730,600
Dividend yield
-
Volume
--
Avg. volume
707,890
P/E ratio
.00

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.66
52 Week Low
$0.01
Market cap
730,600
Dividend yield
-
Volume
--
Avg. volume
707,890
P/E ratio
.00